Legal Representation
Attorney
Karen P. Bechtold
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 11, 2006 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | Loading... |
| Apr 11, 2006 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Apr 10, 2006 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| Apr 10, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 10, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 10, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 20, 2005 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 14, 2005 | I | PAPER RECEIVED | Loading... | |
| Oct 11, 2005 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of artheriosclerotic disease, autoimmune diseases, cancer, cardiovascular diseases, central nervous system diseases, diabetes and other metabolic disorders, inflammation and inflammatory diseases, respiratory and infectious diseases, peripheral and central vascular diseases, seizure disorders, shock and central nervous system trauma, stroke, and viral diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005